(Q83160769)
Statements
Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations (English)
Raymond G Slavin
Caterina Ferioli
Stacey J Tannenbaum
Carmen Martin